摘要:
This invention provides novel crystalline acid salt forms of 7-[(3 R )-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3- a ]pyrazine, i.e . sitagliptin, to processes for their preparation and isolation, and to pharmaceutical compositions comprising the same.